000725025 000__ 04547cam\a2200409Ii\4500
000725025 001__ 725025
000725025 005__ 20230306140508.0
000725025 006__ m\\\\\o\\d\\\\\\\\
000725025 007__ cr\cn\nnnunnun
000725025 008__ 150105s2015\\\\gw\\\\\\o\\\\\001\0\eng\d
000725025 019__ $$a908084804
000725025 020__ $$a9783662449462$$qelectronic book
000725025 020__ $$a3662449463$$qelectronic book
000725025 020__ $$z9783662449455
000725025 035__ $$aSP(OCoLC)ocn899211416
000725025 035__ $$aSP(OCoLC)899211416$$z(OCoLC)908084804
000725025 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dN$T$$dGW5XE$$dE7B$$dUPM$$dOCLCF$$dDKU$$dYDXCP$$dEBLCP
000725025 049__ $$aISEA
000725025 050_4 $$aRC268.3
000725025 08204 $$a616.994079$$223
000725025 24500 $$aCancer immunology$$h[electronic resource] :$$bbench to bedside immunotherapy of cancers /$$cNima Rezaei, editor.
000725025 264_1 $$aBerlin [Germany] :$$bSpringer,$$c[2015]
000725025 300__ $$a1 online resource.
000725025 336__ $$atext$$btxt$$2rdacontent
000725025 337__ $$acomputer$$bc$$2rdamedia
000725025 338__ $$aonline resource$$bcr$$2rdacarrier
000725025 500__ $$aIncludes index.
000725025 5050_ $$aFrontiers in Cancer Immunotherapy -- Novel Strategy of Cancer Immunotherapy: Spiraling Up -- Novel Prognostic Biomarkers for Personalized Cancer Treatments -- Tumor Antigen and Epitope Identification for Pre-Clinical and Clinical Evaluation -- Strategies to Target Tumor Immunesuppression -- Immune Modulation of Drugs in Prevention and Treatment of Cancers -- Overcoming Immune Tolerance With Immune Checkpoint Blockade -- Gene therapy and Virus-Based Cancer Vaccines -- Cancer Stem Cells: Biology and Potential therapeutic Applications -- Hematopoietic Stem Cell Transplantation and Lymphodepletion in Treatment of Cancers -- Combination of Chemotherapy and Cytokine Therapy in Treatment of Cancers -- T Cell Immunotherapy: From Synthetic Biology to Clinical Practice -- Role of Gamma-Delta T Lymphocytes in Cancer Immunosurveillance and Immunotherapy -- Adoptive T Cell therapy: Optimizing Chemokine Receptor-Mediated Homing of T Cells in Cancer Immunotherapy -- Cellular therapy of Cancer With B Effector Cells -- Monoclonal Antibodies for Treatment of Cancers -- Pattern Recognition Receptors in Cancers and Immunotherapy by Triggering or Targeting of Toll Like Receptors Pathway -- Recent Advances in the Use of NK Cells Against Cancer -- Dendritic Cell Vaccines for Cancer Therapy: Fundamentals and Clinical Trials -- Tumor Associated Macrophages and iNOS in Cancer Immunotherapy -- Photodynamic therapy and Anti-Tumor Immune Response -- Polarization of Tumor Milieu: Therapeutic Implications -- Immunotherapies Targeting 5T4 Oncofoetal Glycoprotein -- Immune Monitoring During Clinical Development of Anti-CTLA-4 Antibody Therapy -- PD-1 Blockade in Cancer Therapy -- New Advances in Radioimmunotherapy for the Treatment of Cancers -- Psychoneuroendocrinoimmunotherapy of Cancers -- Ethical Considerations in Cancer Immunotherapy.
000725025 506__ $$aAccess limited to authorized users.
000725025 520__ $$aThis translational book describes in detail the clinical application of novel approaches in cancer immunotherapy with the aim of educating clinicians in the implications of the most recent research and new developments in the field. The scope is broad, encompassing, for example, prognostic biomarkers for personalized cancer treatment, strategies for targeting tumor immunosuppression, gene therapy, virus-based vaccines, targeting of cancer stem cells, hematopoietic stem cell transplantation, the role of T lymphocytes in cancer immunotherapy, use of monoclonal antibodies, and many more innovative approaches. Clinical immunologists, hematologists, and oncologists in particular will find the book to be of value in expanding their knowledge. ℗ℓ The book is the second in a three-volume series, Cancer Immunology, which offers an up-to-date review of cancer immunology and immunotherapy. The remaining volumes focus on the immunopathology of cancers and cancer immunotherapy for organ-specific tumors. In total the series, designed for both clinicians and researchers, includes contributions from more than 250 scientists working at leading universities and institutes from across the world.
000725025 650_0 $$aCancer$$xImmunological aspects.
000725025 7001_ $$aRezaei, Nima,$$eeditor.
000725025 77608 $$iPrint version:$$aRezaei, Nima$$tCancer Immunology : Bench to Bedside Immunotherapy of Cancers$$dBerlin, Heidelberg : Springer Berlin Heidelberg,c2014$$z9783662449455
000725025 852__ $$bebk
000725025 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-662-44946-2$$zOnline Access$$91397441.1
000725025 909CO $$ooai:library.usi.edu:725025$$pGLOBAL_SET
000725025 980__ $$aEBOOK
000725025 980__ $$aBIB
000725025 982__ $$aEbook
000725025 983__ $$aOnline
000725025 994__ $$a92$$bISE